Form 4 for FLGT Fulgent Genetics, Inc.
Accepted 2022-03-02 00:00:00 ET · period of report 2022-02-28 · accession 0001209191-22-014769 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-03-02 | 2022-02-28 | FLGT | KIM PAUL | CFO, Treas | A - Grant | $0.00 | +41.0K | 156.0K | +36% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-28 | A | A | 9,000 | $0.00 | 124,028 | D | — | — | (F1) Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after March 1, 2022, and 1/12th of such shares vesting at the end of every three-month period thereafter over the remaining 24 months, subject to continued service for Issuer on each vesting date. |
| 2 | Common | Common Stock | 2022-02-28 | A | A | 32,000 | $0.00 | 156,028 | D | — | — | (F2) Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after March 1, 2022, and 1/16th of such shares vesting at the end of every three-month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date. |